Drug Profile
RO 324397
Latest Information Update: 08 Nov 2006
Price :
$50
*
At a glance
- Originator Roche
- Class Antivirals
- Mechanism of Action Thymidine kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Herpes simplex virus infections